List of bibliographic references
Number of relevant bibliographic references: 62.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000000 (2005) |
Masahiko Mihara ; Keiko Kasutani ; Makoto Okazaki ; Akito Nakamura ; Shigeto Kawai ; Masamichi Sugimoto ; Yoshihiro Matsumoto ; Yoshiyuki Ohsugi | Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family |
| 000001 (2005) |
Norihiro Nishimoto | Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan |
| 000002 (2005) |
Shumpei Yokota ; Takako Miyamae ; Tomoyuki Imagawa ; Shigeki Katakura ; Rumiko Kurosawa ; Masaaki Mori | Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis |
| 000004 (2006) |
R. N. Maini ; P. C. Taylor ; J. Szechinski ; K. Pavelka ; J. Bröll ; G. Balint ; P. Emery ; F. Raemen ; J. Petersen ; J. Smolen ; D. Thomson ; T. Kishimoto | Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in european patients with rheumatoid arthritis who had an incomplete response to methotrexate |
| 000005 (2006) |
Yasuaki Okuda ; Kiyoshi Takasugi | Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis |
| 000006 (2007) |
Naoko Yoshio-Hoshino ; Yasuo Adachi ; Chieko Aoki ; Alexander Pereboev ; David T. Curiel ; Norihiro Nishimoto | Establishment of a new lnterleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor |
| 000009 (2007) |
Junya Kanda ; Hiroshi Kawabata ; Yuhei Yamaji ; Tatsuo Ichinohe ; Takayuki Ishikawa ; Toshihiro Tamura ; Yutaka Furukawa ; Takeshi Kimura ; Toru Kita ; Takashi Uchiyama | Reversible cardiomyopathy associated with multicentric castleman disease : Successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody |
| 000010 (2007) |
Norihiro Nishimoto ; Jun Hashimoto ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Norikazu Murata ; Désirée Van Der Heijde ; Tadamitsu Kishimoto | Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAL) : evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab |
| 000013 (2008) |
N. Nishimoto ; T. Kishimoto | Humanized Antihuman IL-6 Receptor Antibody, Tocilizumab |
| 000014 (2008) |
Tim Bongartz ; Shumpei Yokota ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Yukoh Aihara ; Shuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto | Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis : a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Commentary |
| 000017 (2008) |
Norihiro Nishimoto ; Hideko Nakahara ; Naoko Yoshio-Hoshino ; Toru Mima | Successful Treatment of a Patient With Takayasu Arteritis Using a Humanized Anti-Interleukin-6 Receptor Antibody |
| 000018 (2008) |
Yasuo Adachi ; Naoko Yoshio-Hoshino ; Norihiro Nishimoto | The Blockade of IL-6 Signaling in Rational Drug Design |
| 000019 (2008) |
Atsuhiko Kato ; Saori Matsuo ; Hirotake Takai ; Yasushi Uchiyama ; Masahiko Mihara ; Masami Suzuki | Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model |
| 000020 (2008) |
Atsushi Taga ; Soichiro Kita ; Kaori Nishiura ; Tomonori Hayashi ; Mitsuhiro Kinoshita ; Atsushi Sato ; Kentaro Suzuki ; Shuji Kodama ; Kazuaki Kakehi | Analysis of an antibody pharmaceutical, tocilizumab, by capillary electrophoresis using a carboxylated capillary |
| 000021 (2008) |
Yasuo Adachi ; Naoko Yoshio-Hoshino ; Norihiro Nishimoto | Gene therapy for Multiple Myeloma |
| 000022 (2008) |
Yasushi Uchiyama ; Hiroto Yoshida ; Nobuo Koike ; Naohiko Hayakawa ; Atsuko Sugita ; Takashi Nishimura ; Masahiko Mihara | Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production |
| 000025 (2008) |
M. Hashizume ; N. Hayakawa ; M. Mihara | IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17 |
| 000028 (2008) |
Norihiro Nishimoto ; Kimio Terao ; Toru Mima ; Hideko Nakahara ; Nobuhiro Takagi ; Takahiro Kakehi | Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease |
| 000030 (2009) |
M. Kawai ; K. Hagihara ; T. Hirano ; Y. Shima ; Y. Kuwahara ; J. Arimitsu ; M. Narazaki ; A. Ogata ; I. Kawase ; T. Kishimoto ; T. Tanaka | Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis |
| 000031 (2009) |
M. Hirao ; J. Hashimoto ; H. Tsuboi ; A. Nampei ; H. Nakahara ; N. Yoshio ; T. Mima ; H. Yoshikawa ; N. Nishimoto | Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab |
| 000034 (2009) |
Kyoko Taniguchi ; Chihiro Shimazaki ; Yoshiko Fujimoto ; Kazuho Shimura ; Hitoji Uchiyama ; Yosuke Matsumoto ; Junya Kuroda ; Shigeo Horiike ; Masafumi Taniwaki | Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PascalFrancis/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA14s3.i -k "JPN"
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA14s3.i \
-Sk "JPN" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= PascalFrancis
|étape= Merge
|type= indexItem
|index= FA14s3.i
|clé= JPN
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
